Irwin Naturals Inc. (IWINF)
| Previous Close | 2.1700 |
| Open | 2.3299 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 2.1700 - 2.1700 |
| 52 Week Range | 0.8000 - 3.9700 |
| Volume | |
| Avg. Volume | 718 |
| Market Cap | 3.276M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 217.00 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Irwin Naturals Cannabis Products Launch Nationwide in Canada
Company announces products being available nationwide through Starseed Medicinal Medical Platform Irwin Naturals Cannabis 25mg CBD Softgel Irwin Naturals Cannabis 25mg CBD Softgel LOS ANGELES, March 24, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), is proud to announce the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical Group platform. CBD 25mg Softgels
- GlobeNewswire
REPEAT - Irwin Naturals Acquires Ketamine Media
Expanding Reach in Rapidly Growing Ketamine Therapy MarketLOS ANGELES, March 22, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is thrilled to announce the successful acquisition of Keta Media, LLC, dba Ketamine Media (“Ketamine Media”) as of March 17, 2023. Ketamine Media is the nation's foremost advertising company dedicated to raising awareness about the clinical use of ketamine. The agreement with Ketamine Media was initially annou
- GlobeNewswire
Irwin Naturals Acquires Ketamine Media
Expanding Reach in Rapidly Growing Ketamine Therapy MarketLOS ANGELES, March 21, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is thrilled to announce the successful acquisition of Keta Media, LLC, dba Ketamine Media (“Ketamine Media”) as of March 17, 2023. Ketamine Media is the nation's foremost advertising company dedicated to raising awareness about the clinical use of ketamine. The agreement with Ketamine Media was initially annou
